Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients

NCT03055286 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

15

Enrollment

INDUSTRY

Sponsor class

Stopped business/strategic reason

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: CWP232291

Sponsor

JW Pharmaceutical